IL308917A - A method for preparing a radiolabeled [18F] compound with low water content during the labeling step - Google Patents
A method for preparing a radiolabeled [18F] compound with low water content during the labeling stepInfo
- Publication number
- IL308917A IL308917A IL308917A IL30891723A IL308917A IL 308917 A IL308917 A IL 308917A IL 308917 A IL308917 A IL 308917A IL 30891723 A IL30891723 A IL 30891723A IL 308917 A IL308917 A IL 308917A
- Authority
- IL
- Israel
- Prior art keywords
- preparing
- water content
- low water
- content during
- radiolabelled compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/005—Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/007—Steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108605.3A GB202108605D0 (en) | 2021-06-16 | 2021-06-16 | Effect of water content |
| PCT/EP2022/066483 WO2022263594A1 (en) | 2021-06-16 | 2022-06-16 | Method for preparing an [18f] radiolabelled compound with low water content during labelling step |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL308917A true IL308917A (en) | 2024-01-01 |
Family
ID=76954450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL308917A IL308917A (en) | 2021-06-16 | 2022-06-16 | A method for preparing a radiolabeled [18F] compound with low water content during the labeling step |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20240366808A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4355715A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024522770A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240021888A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117500773A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022294052A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023026514A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223802A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB202108605D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308917A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023015076A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022263594A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201915206D0 (en) | 2019-10-21 | 2019-12-04 | Ge Healthcare Ltd | Use of cyclodextrins as a radiostabilizer |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0520527D0 (en) | 2005-10-10 | 2005-11-16 | Ge Healthcare Ltd | Automated method |
| EP2053033A1 (en) * | 2007-10-26 | 2009-04-29 | Bayer Schering Pharma AG | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
| AU2011213568B2 (en) | 2010-02-08 | 2016-05-12 | Lantheus Medical Imaging, Inc. | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
| EP2657213A1 (en) * | 2012-04-24 | 2013-10-30 | Institut National de la Santé et de la Recherche Medicale | Labelled quinoxaline derivatives as multimodal radiopharmaceuticals and their precursors |
| DK2880005T3 (en) * | 2012-07-30 | 2016-07-18 | Univ Denmark Tech Dtu | RADIO FLUOR RING PROCEDURE |
| WO2016086036A2 (en) * | 2014-11-25 | 2016-06-02 | Bristol-Myers Squibb Company | Methods and compositions for 18f-radiolabeling of biologics |
| US10716869B2 (en) * | 2016-02-29 | 2020-07-21 | Oncodesign Sa | Radiolabeled macrocyclic EGFR inhibitor |
| ES2907130T3 (es) * | 2017-09-26 | 2022-04-22 | Inst Nat Sante Rech Med | Darapladib radiomarcado, análogos del mismo y su uso como compuestos para la obtención de imágenes |
| GB201805253D0 (en) * | 2018-03-29 | 2018-05-16 | Ge Healthcare Ltd Ip | Solid phase extraction |
-
2021
- 2021-06-16 GB GBGB2108605.3A patent/GB202108605D0/en not_active Ceased
-
2022
- 2022-06-16 EP EP22734290.4A patent/EP4355715A1/en active Pending
- 2022-06-16 AU AU2022294052A patent/AU2022294052A1/en active Pending
- 2022-06-16 IL IL308917A patent/IL308917A/en unknown
- 2022-06-16 US US18/569,180 patent/US20240366808A1/en active Pending
- 2022-06-16 BR BR112023026514A patent/BR112023026514A2/pt unknown
- 2022-06-16 CN CN202280043075.0A patent/CN117500773A/zh active Pending
- 2022-06-16 CA CA3223802A patent/CA3223802A1/en active Pending
- 2022-06-16 MX MX2023015076A patent/MX2023015076A/es unknown
- 2022-06-16 KR KR1020247001158A patent/KR20240021888A/ko active Pending
- 2022-06-16 WO PCT/EP2022/066483 patent/WO2022263594A1/en not_active Ceased
- 2022-06-16 JP JP2023577714A patent/JP2024522770A/ja active Pending
-
2025
- 2025-06-09 US US19/232,774 patent/US20250312494A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022294052A1 (en) | 2023-12-14 |
| EP4355715A1 (en) | 2024-04-24 |
| MX2023015076A (es) | 2024-01-18 |
| GB202108605D0 (en) | 2021-07-28 |
| KR20240021888A (ko) | 2024-02-19 |
| US20250312494A1 (en) | 2025-10-09 |
| CA3223802A1 (en) | 2022-12-22 |
| BR112023026514A2 (pt) | 2024-03-05 |
| WO2022263594A1 (en) | 2022-12-22 |
| JP2024522770A (ja) | 2024-06-21 |
| US20240366808A1 (en) | 2024-11-07 |
| CN117500773A (zh) | 2024-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2472937B (en) | System and method for depth measurement and correction during subsea intervention operations | |
| IL207895A0 (en) | A method for detecting igf1r/chr 15 circulating tumor cells using fish | |
| NZ595227A (en) | Tricyclic indole derivates as pbr ligands | |
| WO2007064819A3 (en) | Devices, systems, and methods for occluding a defect | |
| GB2462602B (en) | Method and apparatus for towing offshore wind turbines | |
| GB2464064A (en) | Methods and systems of installing cable for measurement of a physical parameter | |
| WO2010077572A3 (en) | Method and system of selecting word sequence for text written in language without word boundary markers | |
| EP2035570A4 (en) | PROCESS FOR THE PREPARATION OF AMINO ACIDS USING GLYCERIN | |
| IL165596A0 (en) | System and method for improving heart perfusion inrest and during exercise | |
| HK40108896A (en) | Method for preparing an [18f] radiolabelled compound with low water content during labelling step | |
| ZA202109796B (en) | System and method for preparing methanol therewith | |
| HUE069379T2 (hu) | A glufozinát-ammónium elõállítási eljárása | |
| GB202304953D0 (en) | Preparation method for 2-acetyl-1, 10-phenanthroline | |
| GB202310058D0 (en) | Method for preparing ternary precursor | |
| GB2413658B (en) | Method for correcting seismic data for receiver movement during data acquisition | |
| EG24393A (en) | Method for producing 4-nitroimidazole compound | |
| ZA200608925B (en) | Method for safely logging onto a technical system | |
| PL1794152T3 (pl) | Sposób wytwarzania enancjomerycznych związków imidazolowych | |
| GB2611841B (en) | Method for preparing nanoprobe | |
| GB0400315D0 (en) | Method for reconstructing multimedia object data by means of digital-audio-broadcast (DAB) receivers | |
| ZA202302732B (en) | Method for preparing 4-aminonaphthalene-2,6-dicarboxylic acid | |
| SI4178969T1 (sl) | Postopek za pripravo diosmina | |
| GB202113646D0 (en) | Method of preparation of 18F labelled silyl-fluoride compounds | |
| WO2008149112A3 (en) | Method and apparatus for mounting a pole into the ground | |
| EP2224780A4 (en) | METHOD FOR DETERMINING PAGING TIME INTERVAL DURING WHICH THE BASE STATION EXECUTS UNMOUNTED SERVICE IN A CDMA MOUNTING SYSTEM |